Speaking at the B20 Health Conference in Berlin, IFPMA Director-General […]
Read moreThe new report on The Impact of Biosimilar Competition in […]
Read moreThe European pharmaceutical industry welcomes the 3rd workshop on access […]
Read moreOver 100 participants explored different ways and opportunities to ensure […]
Read moreBiosimilar medicines are a part of today’s therapeutic armamentarium – […]
Read moreA special satellite symposium was organized on “Value added medicines […]
Read moreWith 10 years of positive experience with biosimilar medicines, medical […]
Read moreKey authorities, eminent lawyers and industry leaders discussed today in […]
Read moreUS FDA interchangeability guidance adds another level of confusion over […]
Read more